Crescent Capital BDC (CCAP) Q3 2026 earnings review
Crescent BDC covers its dividend, but asset values fall again
Crescent Capital BDC, a lender to mid-sized companies, stabilized its quarterly cash profit while its loan book value slipped again. Net investment income edged up to $0.37 per share as average loan yields held at 9.6%, clearing the $0.34 regular dividend. Book value per share still fell for a ninth straight quarter to $17.72 on fresh loan markdowns.
| Net investment income per share | $0.37 -20% from a year ago; +3% from Q2 |
|---|---|
| Net asset value per share | $17.72 -0.6% from last quarter; -8.1% from a year ago |
| Net debt-to-equity ratio | 1.36x 1.37x last quarter (target: 1.1x–1.3x) |
| Q4 regular dividend outlook | Unchanged $0.34 per share base plus final $0.03 special |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because slower portfolio losses and a new $75 million buyback pledge from the company and parent Sun Life are offset by high debt and unread credit metrics. Net repayments of $15 million barely nudged net debt-to-equity down to 1.36x, leaving roughly $39 million of debt reduction needed in the fourth quarter by our math to hit the 1.3x target ceiling.
The question now is whether the slower pace of book value erosion marks the end of loan defaults or just a quiet quarter between restructurings. Either credit quality has stabilized in the core portfolio, or the 15% watchlist from June will drive another wave of write-downs. The non-accrual and risk-rating tables in the third-quarter 10-Q filing will settle it.
🐂 Bull Case
Portfolio Yield Held Steady and Lifted Core Profit
Crescent Capital BDC lends money to mid-sized businesses, and 98.2% of its loans carry floating interest rates. Over the past year, falling benchmark rates pushed the average yield on its performing loans down from 10.4% to 9.6%. This quarter that yield stopped falling and held at 9.6%.
Total investment income edged up to $36.9 million from $36.3 million last quarter, "primarily driven by higher recurring interest income from investment due to higher benchmark rates during the quarter", Crescent BDC said. Net investment income — the cash profit after expenses and taxes used to pay dividends — rose to $0.37 per share from $0.36. Even without $0.5 million of one-time loan payoff fees, core profit was about $0.36 per share by our math, clearing the $0.34 regular dividend.
What to watch: the average yield on performing loans in the fourth quarter. A stable reading near 9.6% would keep core profit safely above the $0.34 base payout after the special dividends end in December.
New $75 Million Buyback Commitment Backs the Portfolio
Crescent BDC is managed by an arm of insurer Sun Life, and management has pointed to that backing as a strength. Under an earlier $20 million share repurchase plan that expired in September, the lender bought back fewer than 124,000 shares in the first half of the year and none in the third quarter.
On November 5, the board approved a new $50 million share repurchase programme. Separately, Sun Life plans to "purchase up to an additional $25 million of the Company’s common stock in the open market", the release said. Both plans will be "executed by an independent third-party broker pursuant to a Rule 10b5-1 trading plan", which automates purchases under preset rules and equals 11.5% of total net assets by our math.
What to watch: the actual share count reduction in fourth-quarter results. Because the prior plan went mostly unused, only completed purchases will prove the automated trading rules are set to buy.
🐻 Bear Case
Asset Values Fell for a Ninth Straight Quarter
Net asset value (NAV) per share — the accounting value of the loan book minus debt — has fallen every quarter since mid-2024. In the third quarter it slipped another $0.10, or 0.6%, to $17.72 per share, and is now down 8.1% from $19.28 a year ago.
- Realized losses on investments, net of taxes: $2.1 million ($0.06 per share), down from $17.7 million in Q2
- Unrealized markdowns on non-controlled investments: $5.7 million, partly offset by $4.3 million of gains on controlled companies
- Accumulated deficit on the balance sheet: $302.5 million, widened from $251.0 million at year-end 2025
While the $0.10 drop was much smaller than the $0.45 decline in the second quarter and the $0.83 drop in the first, the portfolio is still losing value each quarter. Core profit beat the regular dividend by $0.03 per share, which restored the $0.03 special dividend paid out of net assets, so the entire $0.10 per share erosion came from investment losses.
What to watch: fourth-quarter net unrealized gains or losses on non-controlled loans. Until markdowns on standard corporate loans stop exceeding gains, book value per share will keep shrinking.
Debt Load Remains Above Target With One Quarter Left
Management wants net debt-to-equity — borrowed money minus cash, divided by shareholder equity — between 1.1x and 1.3x, and aimed to get back inside that band during the second half of 2026. In the third quarter the lender invested $23.5 million and collected $38.7 million from loan exits and repayments, generating $15.2 million of net repayments by our math.
That pullback barely moved the ratio, which edged down to 1.36x from 1.37x in June because ongoing loan markdowns shrank the equity base at the same time. By our math, reaching the 1.30x top of the target range by December requires another $39 million of net debt reduction, while spending cash on the new $50 million share buyback would push leverage up.
What to watch: net funded investment activity in the fourth quarter. Crescent BDC needs loan repayments to exceed new lending by roughly $40 million to meet its year-end leverage goal.
Borrowing Costs and Joint Venture Cuts Squeeze Margins
Crescent BDC lowered its base management fee to 1.00% and its incentive fee to 15.0% in April to protect shareholder payouts. That fee cut reduced combined management and incentive fees by 3.7 percentage points of total investment income compared with a year ago, down to 17.3% by our math.
Higher borrowing costs and shrinking joint venture payouts outweighed those savings. Interest and debt financing costs climbed by 7.3 percentage points of revenue from a year ago to 40.8%, as the average interest rate on its debt reached 6.26%. Meanwhile, dividend income fell 25% from last quarter to $0.9 million, "primarily reflecting lower distributions from the Company’s Logan JV investment", the lender said.
What to watch: dividend income from controlled investments next quarter. It fell from $1.96 million a year ago to $0.72 million this quarter, and further drops directly reduce cash profit.
Risks this quarter didn't answer
The earnings release omits the credit quality tables that live in the full quarterly filing and conference call remarks, leaving four standing credit risks unreadable today.
- Loans on non-accrual (overdue loans no longer recording interest): 4.8% of debt at cost and 2.5% at fair value in Q2; Note 2 of the 10-Q will show if new defaults appeared.
- Internal watchlist ratings: loans rated 3 (performing below expectations) rose to 12% of the book in Q2 alongside 3% in ratings 4 and 5; the 10-Q MD&A table will show if migration continued.
- Healthcare concentration: 25% of the portfolio in Q2 and the source of recent defaults; Note 4 of the 10-Q will update industry weights.
- Legacy First Eagle rotation and restructured equity: 27 acquired investments remained in Q2, and controlled equity marks rose $4.3 million in Q3; prepared call remarks will detail individual exits.
💲 Other KPIs
Non-cash interest rose 30% from last quarter's $1.95 million and made up 6.9% of total investment income by our math, up from 5.4% in the second quarter. Paid-in-kind (PIK) interest is added to a borrower's loan balance instead of paid in cash, so rising PIK means more reported profit is not yet collected in cash.
Senior secured first lien and unitranche loans — debt that has first claim on a borrower's assets — totalled $1,410.1 million across 190 companies, edging up from 89.5% of the $1,555.2 million portfolio at the end of 2025. Equity positions and junior debt stayed below 10% of fair value.
Available borrowing capacity rose from $199.6 million in June as the US lender used net loan repayments to pay down its credit lines. Total cash and restricted cash also increased slightly to $36.2 million from $35.7 million last quarter.
🔮 Guidance
Unchanged. The board declared a $0.34 per share regular payout for the fourth quarter, payable January 15, 2027, matching the reset level put in place after the first quarter. Third-quarter net investment income of $0.37 per share covered this base rate by $0.03.
Unchanged. Crescent BDC will pay the third and final installment of its previously announced $0.09 special dividend on December 15, 2026. Unless the board announces a new supplemental programme next year, total quarterly payouts will step down from $0.37 to the $0.34 regular rate in early 2027.
❓ Key Questions
Did non-accrual loans and watchlist credits stop rising in Q3?
The earnings release did not include the non-accrual percentage or internal risk ratings. In the second quarter, loans performing below expectations rose to 12% of the book, so the 10-Q table will show if credit problems are still spreading.
How will management balance $50 million of buybacks against deleveraging?
Net debt-to-equity is 1.36x against a 1.1x to 1.3x target. Every dollar spent buying back shares uses cash that could pay down debt and shrinks the equity denominator, pushing leverage higher unless loan repayments speed up.
What is the remaining value and payout run-rate of the Logan JV?
Controlled dividend income fell to $0.72 million from $1.96 million a year ago as the Logan joint venture winds down. Investors need to know how much further this quarterly income stream can fall.
Why did paid-in-kind interest jump 30% from last quarter?
Total PIK interest rose to $2.54 million, or 6.9% of investment income by our math. Management has not said whether that increase came from struggling borrowers amending their loans to defer cash interest.